|
(P1476)
|
"Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study" (language: en)
|
|
(P2860)
|
(Q40437100)
(Q48414534)
(Q36963184)
(Q57912405)
(Q48176144)
(Q28293763)
(Q28255548)
(Q29614225)
(Q29547525)
(Q36400329)
(Q36367147)
(Q24290619)
(Q71610356)
(Q28266133)
(Q36365596)
(Q48412662)
(Q35957193)
(Q24338636)
(Q48442189)
(Q38363544)
(Q29620481)
(Q72427037)
(Q34575334)
(Q79755041)
(Q73197820)
(Q82263194)
(Q40796002)
(Q81245834)
(Q80250281)
(Q22252943)
(Q22241644)
(Q40810823)
(Q30640097)
(Q30573085)
(Q93569390)
(Q28280453)
(Q28280465)
(Q36259695)
(Q34472062)
(Q79718082)
(Q28284231)
(Q54270046)
(Q34411828)
(Q36368672)
(Q34651378)
(Q48200750)
(Q28268626)
|